What impact do the proton pump inhibitors have on the efficacy of immune check point inhibitors in metastatic malignant melanoma?

被引：17
|
作者：
Afzal, Muhammad Zubair [1 ]
Shirai, Keisuke [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e21040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21040
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world analysis of usage and efficacy of immune check point inhibitors in recurrent/metastatic head and neck cancers
    Domadia, K. R.
    Pandya, N.
    Mandlik, D.
    Patel, D.
    Jani, K.
    Patel, P.
    Patel, P. D.
    Batham, S.
    Hirapara, P. H.
    Modi, V. K.
    Joshipura, A.
    Sharma, N.
    Shah, A.
    Gandhi, M.
    Toprani, D.
    Toprani, R.
    Patel, K.
    ANNALS OF ONCOLOGY, 2024, 35
  • [22] Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
    Lopes, Sebastien
    Pabst, Lucile
    Dory, Anne
    Klotz, Marion
    Gourieux, Benedicte
    Michel, Bruno
    Mascaux, Celine
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
    Ziogas, Dimitrios C.
    Theocharopoulos, Charalampos
    Koutouratsas, Tilemachos
    Haanen, John
    Gogas, Helen
    CANCER TREATMENT REVIEWS, 2023, 113
  • [24] Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients
    Homicsko, K.
    Richtig, G.
    Tuchmann, F.
    Tsourti, Z.
    Hanahan, D.
    Coukos, G.
    Wind-Rotolo, M.
    Richtig, E.
    Zygoura, P.
    Holler, C.
    Dafni, U.
    Michielin, O. A.
    ANNALS OF ONCOLOGY, 2018, 29 : 40 - 40
  • [25] Intracerebral Efficacy of Immune Check-Point Inhibitors in NSCLC Patients with Brain Metastases
    Ohyanagi, F.
    Shiihara, J.
    Kudo, F.
    Mizushina, Y.
    Ota, H.
    Koyama, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S897 - S897
  • [26] The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
    Buti, Sebastiano
    Tommasi, Chiara
    Scartabellati, Giulia
    De Giorgi, Ugo
    Brighi, Nicole
    Rebuzzi, Sara Elena
    Puglisi, Silvia
    Caffo, Orazio
    Kinspergher, Stefania
    Mennitto, Alessia
    Cattrini, Carlo
    Santoni, Matteo
    Verzoni, Elena
    Rametta, Alessandro
    Stellato, Marco
    Malgeri, Andrea
    Roviello, Giandomenico
    de Filippo, Massimo
    Cortellini, Alessio
    Bersanelli, Melissa
    ANTI-CANCER DRUGS, 2023, 34 (01) : 178 - 186
  • [27] What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?
    Kikuta, Shogo
    Abe, Yushi
    Hino, Kiyosato
    Imai, Sho
    Matsuo, Katsuhisa
    Shinozaki, Katsumi
    Nakamura, Moriyoshi
    Seki, Naoko
    Kusukawa, Jingo
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (04)
  • [28] Do Proton Pump Inhibitors Impact Clinical Outcomes in Staphylococcus Aureus Bacteremia?
    Caffrey, Aisling R.
    Timbrook, Tristan T.
    Sakoulas, George
    LaPlante, Kerry L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 469 - 470
  • [29] Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors
    Stucci, Luigia Stefania
    D'Oronzo, Stella
    Tucci, Marco
    Macerollo, Antonella
    Ribero, Simone
    Spagnolo, Francesco
    Marra, Elena
    Picasso, Virginia
    Orgiano, Laura
    Marconcini, Riccardo
    De Rosa, Francesco
    Di Guardo, Lorenza
    Galli, Giulia
    Gandini, Sara
    Palmirotta, Raffaele
    Palmieri, Giuseppe
    Queirolo, Paola
    Silvestris, Francesco
    CANCER TREATMENT REVIEWS, 2018, 69 : 21 - 28
  • [30] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
12345